Exeliom Biosciences is an emerging biotechnology company specialized in the development of a novel category of drugs, called Live Biotherapeutics, to treat Inflammatory Bowel Diseases using the unique therapeutic properties of monoclonal microbial strains sourced from the human gut microbiota.